Magnetic nanoparticle design for medical diagnosis and therapy

Magnetic nanoparticles have attracted attention because of their current and potential usefulness as contrast agents for magnetic resonance imaging (MRI) or colloidal mediators for cancer magnetic hyperthermia. This review examines these in vivo applications through an understanding of the involved problems and the current and future possibilities for resolving them. A special emphasis is made on magnetic nanoparticle requirements from a physical viewpoint (e.g. relaxivity for MRI and specific absorption rate for hyperthermia), the factors affecting their biodistribution (e.g. size, surface hydrophobic/hydrophilic balance, etc.) and the solutions envisaged for enhancing their half-life in the blood compartment and targeting tumour cells.

[1]  H. Honda,et al.  Effective Solitary Hyperthermia Treatment of Malignant Glioma Using Stick Type CMC-magnetite. In vivo Study , 2004, Journal of Neuro-Oncology.

[2]  J Szebeni,et al.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.

[3]  Wolfgang Ebert,et al.  Tissue-specific MR contrast agents. , 2003, European journal of radiology.

[4]  M. Bellin,et al.  Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography , 2003, Abdominal Imaging.

[5]  Sung-Wook Choi,et al.  Surface Modification of Functional Nanoparticles for Controlled Drug Delivery , 2003 .

[6]  P. Moroz,et al.  Hepatic clearance of arterially infused ferromagnetic particles , 2003, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[7]  J. Bulte,et al.  Magnetoliposomes as contrast agents. , 2003, Methods in enzymology.

[8]  P. Reimer,et al.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications , 2003, European Radiology.

[9]  Timothy Ravasi,et al.  The mononuclear phagocyte system revisited , 2002, Journal of leukocyte biology.

[10]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[11]  P. Moroz,et al.  Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model , 2002, Journal of surgical oncology.

[12]  P. Moroz,et al.  Arterial embolization hyperthermia in porcine renal tissue. , 2002, The Journal of surgical research.

[13]  Rares Salomir,et al.  Automatic control of hyperthermic therapy based on real‐time Fourier analysis of MR temperature maps , 2002, Magnetic resonance in medicine.

[14]  T. S. St. Pierre,et al.  Arterial embolization hyperthermia: hepatic iron particle distribution and its potential determination by magnetic resonance imaging. , 2002, Physics in medicine and biology.

[15]  Nathan Kohler,et al.  Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. , 2002, Biomaterials.

[16]  D D Allen,et al.  Nanoparticle Technology for Drug Delivery Across the Blood-Brain Barrier , 2002, Drug development and industrial pharmacy.

[17]  P. Moroz,et al.  Magnetically mediated hyperthermia: current status and future directions , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[18]  Y Rabin,et al.  Is intracellular hyperthermia superior to extracellular hyperthermia in the thermal sense? , 2002, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[19]  Jun Yoshida,et al.  Targeting Hyperthermia for Renal Cell Carcinoma Using Human MN Antigenspecific Magnetoliposomes , 2001, Japanese journal of cancer research : Gann.

[20]  A. Vekris,et al.  Synthesis, magnetic properties, surface modification and cytotoxicity evaluation of Y3Fe5−xAlxO12 (0⩽x⩽2) garnet submicron particles for biomedical applications , 2001 .

[21]  O. S. Nielsen,et al.  A future for hyperthermia in cancer treatment? , 2001, European journal of cancer.

[22]  P. Moroz,et al.  Targeting liver tumors with hyperthermia: Ferromagnetic embolization in a rabbit liver tumor model , 2001, Journal of surgical oncology.

[23]  P. Moroz,et al.  Status of hyperthermia in the treatment of advanced liver cancer , 2001, Journal of Surgical Oncology.

[24]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[25]  J. Kreuter,et al.  Nanoparticulate systems for brain delivery of drugs. , 2001, Advanced drug delivery reviews.

[26]  Peter Babinec,et al.  SUPERPARAMAGNETIC GEL AS A NOVEL MATERIAL FOR ELECTROMAGNETICALLY INDUCED HYPERTHERMIA , 2001 .

[27]  M. Cuyper,et al.  Investigation of the spontaneous transferability of a phospholipid-poly(ethylene glycol)-biotin derivative from small unilamellar phospholipid vesicles to magnetoliposomes , 2001 .

[28]  Jun Yoshida,et al.  Preparation of Tumor-Specific Magnetoliposomes and Their Application for Hyperthermia , 2001 .

[29]  A. V. Sergeev,et al.  Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro , 2001 .

[30]  V. Mazokhin,et al.  Technical aspects of electromagnetic hyperthermia in medicine. , 2001, Critical reviews in biomedical engineering.

[31]  S. Loening,et al.  Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermia , 2001 .

[32]  P. Couvreur,et al.  Design of folic acid-conjugated nanoparticles for drug targeting. , 2000, Journal of pharmaceutical sciences.

[33]  S M Moghimi,et al.  Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. , 2000, Trends in biotechnology.

[34]  Robert E. Lenkinski,et al.  Gadolinium-Loaded Nanoparticles: New Contrast Agents for Magnetic Resonance Imaging , 2000 .

[35]  P. Couvreur,et al.  Targeted delivery of antibiotics using liposomes and nanoparticles: research and applications. , 2000, International journal of antimicrobial agents.

[36]  R. Brooks,et al.  Relaxometry and magnetometry of the MR contrast agent MION‐46L , 1999, Magnetic resonance in medicine.

[37]  W. Kaiser,et al.  Application of magnetite ferrofluids for hyperthermia , 1999 .

[38]  P. Wust,et al.  Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles , 1999 .

[39]  Okuhata,et al.  Delivery of diagnostic agents for magnetic resonance imaging. , 1999, Advanced drug delivery reviews.

[40]  J. Bulte,et al.  Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .

[41]  Peter Wust,et al.  Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro , 1999 .

[42]  R. Dorshow,et al.  Polyethyleneglycol-stabilized manganese-substituted hydroxylapatite as a potential contrast agent for magnetic resonance imaging: particle stability in biologic fluids. , 1998, Investigative radiology.

[43]  W. Kaiser,et al.  Physical limits of hyperthermia using magnetite fine particles , 1998 .

[44]  Moghimi,et al.  Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity. , 1998, Advanced drug delivery reviews.

[45]  J. Bacri,et al.  Biomedical applications of maghemite ferrofluid. , 1998, Biochimie.

[46]  K. Briley-Saebo,et al.  Crystal size and properties of superparamagnetic iron oxide (SPIO) particles. , 1997, Magnetic resonance imaging.

[47]  P Wust,et al.  Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. , 1997, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[48]  P Wust,et al.  Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. , 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[49]  R Weissleder,et al.  MR of carcinoma-specific monoclonal antibody conjugated to monocrystalline iron oxide nanoparticles: the potential for noninvasive diagnosis. , 1996, AJNR. American journal of neuroradiology.

[50]  M. Kamihira,et al.  Preparation and characteristics of magnetite‐labelled antibody with the use of poly(ethylene glycol) derivatives , 1995, Biotechnology and applied biochemistry.

[51]  P. Gasper,et al.  Hyperthermic therapy for HIV infection. , 1995, Medical hypotheses.

[52]  M. Shinkai,et al.  Antibody‐conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia , 1995, Biotechnology and applied biochemistry.

[53]  P. Jacobs,et al.  Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[54]  C. W. Jung Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. , 1995, Magnetic resonance imaging.

[55]  G. A. Mercier On the molecular spin density and the electrostatic potential as determinants of the relaxivity of metalloporphyrins. , 1995, Magnetic resonance imaging.

[56]  K. Caldwell,et al.  Surface Properties of Pluronic-Coated Polymeric Colloids , 1994 .

[57]  R Weissleder,et al.  MR lymphography: study of a high-efficiency lymphotrophic agent. , 1994, Radiology.

[58]  R. Demeure,et al.  Spin labelled arabinogalactan as MRI contrast agent. , 1994, Magnetic resonance imaging.

[59]  G. Frija,et al.  MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement. , 1994, AJR. American journal of roentgenology.

[60]  P. Bunn,et al.  Synthesis and evaluation of colloidal magnetic iron oxides for the site-specific radiofrequency-induced hyperthermia of cancer , 1993 .

[61]  Ralph Weissleder,et al.  Colloidal magnetic resonance contrast agents : effect of particle surface on biodistribution , 1993 .

[62]  B. Scaife,et al.  Relaxation and resonance in ferrofluids , 1993 .

[63]  J. Bulte,et al.  Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.

[64]  S. Mann,et al.  Magnetoferritin: in vitro synthesis of a novel magnetic protein. , 1992, Science.

[65]  M. Bernardino,et al.  Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. , 1992, Radiology.

[66]  R. Brasch,et al.  Rationale and applications for macromolecular Gd‐based contrast agents , 1991, Magnetic resonance in medicine.

[67]  A. Fischman,et al.  Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. , 1991, Radiology.

[68]  P. C. Fannin Measurement of the Neel relaxation of magnetic particles in the frequency range 1 kHz to 160 MHz , 1991 .

[69]  R. Weissleder,et al.  Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. , 1990, Radiology.

[70]  B. Künnecke,et al.  Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors , 1989, Magnetic resonance in medicine.

[71]  R Weissleder,et al.  Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.

[72]  B. Genetet,et al.  A new immunoreagent for cell labeling. CD3 monoclonal antibody covalently coupled to fluorescent polymethacrylic nanoparticles. , 1988, Journal of immunological methods.

[73]  M. Kumakura,et al.  Polyacrolein microspheres as immunoreagents. , 1983, Journal of immunological methods.

[74]  C. Gitler,et al.  The selective detection of cell surface determinants by means of antibodies and acetylated avidin attached to highly fluorescent polymer microspheres. , 1983, Biochimica et biophysica acta.

[75]  R. Gilchrist,et al.  Selective Inductive Heating of Lymph Nodes , 1957, Annals of surgery.